Widowmaker Right Coronary Artery Treated With Drug-Eluting Stent Implantation

Gurpreet Singh1, Nicholas A Schreiter2, Steven W Schreiter1

  • 1Department of Cardiovascular Medicine, Mayo Clinic Health Systems, Eau Claire, Wisconsin.

JACC. Case Reports
|July 28, 2021
PubMed

Insights

A rare single coronary artery anomaly originating from the right sinus of Valsalva presented with a significant blockage. Treatment with a drug-eluting stent resulted in sustained symptom relief for 14 years.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Congenital Heart Disease

Background:

  • A single coronary artery system is a rare congenital anomaly.
  • Anomalous coronary origins can lead to myocardial ischemia and infarction.
  • Obstructive lesions in single coronary arteries pose unique management challenges.

Purpose of the Study:

  • To report a case of a single coronary artery arising from the right sinus of Valsalva.
  • To describe the management of an obstructive mid-vessel lesion in this anomaly.
  • To evaluate the long-term outcome of percutaneous coronary intervention in such a case.

Main Methods:

  • Diagnostic coronary angiography to delineate the anomalous coronary anatomy.
  • Stress testing to assess for functional ischemia.
  • Percutaneous coronary intervention with a first-generation drug-eluting stent.

Main Results:

  • The patient had a single coronary artery originating from the right sinus of Valsalva with a mid-vessel obstructive lesion.
  • Stress testing confirmed functional evidence of ischemia.
  • Successful stenting with a Cypher drug-eluting stent was performed.
  • The patient remained asymptomatic at 14-year follow-up.

Conclusions:

  • A single coronary artery system from the right sinus of Valsalva can be successfully managed with percutaneous coronary intervention.
  • Drug-eluting stents provide durable long-term results in treating obstructive lesions in anomalous coronary arteries.
  • This case highlights the importance of comprehensive assessment and tailored treatment for rare coronary anomalies.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
74
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
62
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
80
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
82
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
58
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
292